These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M; Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865 [TBL] [Abstract][Full Text] [Related]
6. Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now? Dzeshka MS; Lip GY Trends Cardiovasc Med; 2015 May; 25(4):315-36. PubMed ID: 25440108 [TBL] [Abstract][Full Text] [Related]
7. [Current management of antithrombotic treatment in patients with non valvular atrial fibrillation and prior history of stroke or transient ischemic attack]. Masjuán J; Álvarez-Sabín J; Blanco M; de Felipe A; Gil-Núñez A; Gállego-Culleré J; Vivancos J Rev Neurol; 2014 Jul; 59(1):25-36. PubMed ID: 24965928 [TBL] [Abstract][Full Text] [Related]
9. Antithrombotic treatment in atrial fibrillation. Lip GY; Boos CJ Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982 [TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of anticoagulation with vitamin K antagonists in acute stroke patients with atrial fibrillation--Hungarian results]. Sas A; Csontos K; Lovász R; Valikovics A Ideggyogy Sz; 2015 Jan; 68(1-2):47-51. PubMed ID: 25842916 [TBL] [Abstract][Full Text] [Related]
11. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry. Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013 [TBL] [Abstract][Full Text] [Related]
12. Novel oral anticoagulants in secondary prevention of stroke. Diener HC; Easton JD; Hankey GJ; Hart RG Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901 [TBL] [Abstract][Full Text] [Related]
13. Stroke prevention in atrial fibrillation: do we still need warfarin? Diener HC; Weber R; Lip GY; Hohnloser SH Curr Opin Neurol; 2012 Feb; 25(1):27-35. PubMed ID: 22143201 [TBL] [Abstract][Full Text] [Related]
14. The prestroke use of vitamin K antagonists for atrial fibrillation - trends over 15 years. Bembenek JP; Karliński M; Kobayashi A; Członkowska A Int J Clin Pract; 2015 Feb; 69(2):180-5. PubMed ID: 25358816 [TBL] [Abstract][Full Text] [Related]
15. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272 [TBL] [Abstract][Full Text] [Related]
16. [Antiplatelet and anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation: evidence based strategies and new developments]. Gersh BJ; Freedman JE; Granger CB Rev Esp Cardiol; 2011 Apr; 64(4):260-8. PubMed ID: 21411211 [No Abstract] [Full Text] [Related]
17. [Antithrombotic and anticoagulation therapy after stroke and transient ischemic attacks]. Weber R; Frank B; Diener HC Nervenarzt; 2010 Dec; 81(12):1509-17; quiz 1518-9. PubMed ID: 21181335 [TBL] [Abstract][Full Text] [Related]
18. Management and 1-year outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events. Zubaid M; Rashed WA; Alsheikh-Ali AA; Al-Zakwani I; AlMahmeed W; Shehab A; Sulaiman K; Qudaimi AA; Asaad N; Amin H; Angiology; 2015 May; 66(5):464-71. PubMed ID: 24904179 [TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complications. Barrios V; Escobar C Expert Rev Cardiovasc Ther; 2013 Feb; 11(2):129-41. PubMed ID: 23405833 [TBL] [Abstract][Full Text] [Related]
20. Will warfarin ever be replaced? Ruff CT; Braunwald E J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):210-9. PubMed ID: 20484119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]